Cholera - Pipeline Review, H1 2015

Publisher Name :
Date: 30-Jan-2015
No. of pages: 45
Inquire Before Buying

Global Markets Direct's, ‘Cholera Pipeline Review, H1 2015', provides an overview of the Cholera's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Cholera, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cholera and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global therapeutic landscape of Cholera

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Cholera and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Cholera products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Cholera pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products


Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Cholera

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Cholera pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Cholera - Pipeline Review, H1 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Cholera Overview 6
Therapeutics Development 7
Pipeline Products for Cholera - Overview 7
Pipeline Products for Cholera - Comparative Analysis 8
Cholera - Therapeutics under Development by Companies 9
Cholera - Therapeutics under Investigation by Universities/Institutes 10
Cholera - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Cholera - Products under Development by Companies 14
Cholera - Products under Investigation by Universities/Institutes 15
Cholera - Companies Involved in Therapeutics Development 16
Beijing Minhai Biotechnology Co., Ltd 16
Napo Pharmaceuticals, Inc. 17
PaxVax 18
Cholera - Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
Assessment by Mechanism of Action 21
Assessment by Route of Administration 22
Assessment by Molecule Type 23
Drug Profiles 25
AKT-10082 - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
cholera (trivalent) vaccine - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
crofelemer DR - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Peptide for Cholera and Guillain-Barre Syndrome - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
PXVX-0200 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Cholera - Recent Pipeline Updates 31
Cholera - Dormant Projects 35
Cholera - Discontinued Products 36
Cholera - Product Development Milestones 37
Featured News & Press Releases 37
Dec 08, 2014: PaxVax Announces Primary Endpoints Met in Phase 3 Cholera Vaccine Trial 37
Sep 30, 2014: Specialty Vaccine Company PaxVax to Present at 13th Annual BIO Investor Forum 37
Jul 01, 2014: Specialty Vaccine Company PaxVax Announces Positive Efficacy Results for Phase 3 Cholera Challenge Study 38
May 27, 2014: Specialty Vaccine Company PaxVax to Present at the Jefferies 2014 Global Healthcare Conference 39
Jan 09, 2014: PaxVax Announces Positive Interim Results for Phase 3 Cholera Challenge Study; Clinical Trial Program to Proceed as Planned 39
Sep 06, 2013: PaxVax Initiates Phase 3 Clinical Trial Challenge Studies for Single-Dose Oral Cholera Vaccine 41
Nov 14, 2012: PaxVax Presents Phase I Clinical Trial Results Of Single-dose Cholera Vaccine At 2012 ASTMH Annual Meeting 42
Mar 19, 2012: FDA Accepts PaxVax's IND For Single-Dose Oral Cholera Vaccine 42
Appendix 44
Methodology 44
Coverage 44
Secondary Research 44
Primary Research 44
Expert Panel Validation 44
Contact Us 44
Disclaimer 45

List of Tables

Number of Products under Development for Cholera, H1 2015 7
Number of Products under Development for Cholera - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Late Stage Development, H1 2015 11
Comparative Analysis by Clinical Stage Development, H1 2015 12
Comparative Analysis by Early Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Products under Investigation by Universities/Institutes, H1 2015 15
Cholera - Pipeline by Beijing Minhai Biotechnology Co., Ltd, H1 2015 16
Cholera - Pipeline by Napo Pharmaceuticals, Inc., H1 2015 17
Cholera - Pipeline by PaxVax, H1 2015 18
Assessment by Monotherapy Products, H1 2015 19
Number of Products by Stage and Target, H1 2015 20
Number of Products by Stage and Mechanism of Action, H1 2015 21
Number of Products by Stage and Route of Administration, H1 2015 22
Number of Products by Stage and Molecule Type, H1 2015 24
Cholera Therapeutics - Recent Pipeline Updates, H1 2015 31
Cholera - Dormant Projects, H1 2015 35
Cholera - Discontinued Products, H1 2015 36

List of Figures

Number of Products under Development for Cholera, H1 2015 7
Number of Products under Development for Cholera - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 13
Assessment by Monotherapy Products, H1 2015 19
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 22
Number of Products by Top 10 Molecule Types, H1 2015 23
Number of Products by Stage and Top 10 Molecule Types, H1 2015 24

  • Global Drugs For Herpes Labialis (Oral Herpes) Sales Market Report 2018
    Published: 19-Jan-2018        Price: US 4000 Onwards        Pages: 113
    In this report, the global Drugs For Herpes Labialis (Oral Herpes) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Drugs For Herpes Labialis (Oral Herpes) for these regions, from 2013 to 2025 (forecast), covering - United States......
  • Global Sepsis Partnering Market Research Report 2018
    Published: 19-Jan-2018        Price: US 2900 Onwards        Pages: 107
    In this report, the global Sepsis Partnering market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sepsis Partnering in these regions, from 2013 to 2025 (forecast), covering - North America - Europe - China -......
  • Anthrax - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 109
    Anthrax - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anthrax - Pipeline Review, H1 2018, provides an overview of the Anthrax (Infectious Disease) pipeline landscape. Anthrax is a serious infectious disease caused by Bacillus anthracis. Signs and symptoms include nausea, vomiting, abdominal pain, headache, loss of appetite, fever, severe, bloody diarrhea in the later stages of the ......
  • Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 68
    Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2018, provides an overview of the Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline landscape. Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ......
  • Sepsis - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 301
    Sepsis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sepsis - Pipeline Review, H1 2018, provides an overview of the Sepsis (Infectious Disease) pipeline landscape. Sepsis is an illness in which the body has a severe response to bacteria or other germs. Sepsis occurs when chemicals released into the bloodstream to fight the infection trigger inflammation throughout the body. This re......
  • Typhoid Fever - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 46
    Typhoid Fever - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Typhoid Fever - Pipeline Review, H1 2018, provides an overview of the Typhoid Fever (Infectious Disease) pipeline landscape. Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi (S. typhi). Symptoms include abdominal tenderness, agitation, chi......
  • Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2018
    Published: 18-Jan-2018        Price: US 2000 Onwards        Pages: 22
    Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2018, provides an overview of the Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline landscape. Elephantiasis commonly known as Lymphatic filariasis occurs when filarial parasites are transmitted to humans through mosquitoes. ......
  • 2015-2023 World Cephalosporin Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 18-Jan-2018        Price: US 2800 Onwards        Pages: 183
    Summary Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.Cephalosporin originally derived from the fungus Acremonium, which was previously known as ""Cephalosporium" This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as ......
  • Global Polymixin Market Research Report 2018
    Published: 16-Jan-2018        Price: US 3500 Onwards        Pages: 115
    Summary Market Segment as follows: By Region Asia-Pacific (Segment by Company, Type and Application) North America (Segment by Company, Type and Application) Europe (Segment by Company, Type and Application) South America (Segment by Company, Type and Application) Middle East & Africa (Segment by Company, Type and Application) By ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs